Bruno Speder is an accomplished professional in strategic regulatory affairs, currently serving as Vice President of Regulatory Affairs at Aletheia Life Science Consulting and Poolbeg Pharma. With a strong background in regulatory management, Bruno has previously held positions such as Director of Global Regulatory Affairs at EverImmune and Vice President of Regulatory Affairs at Open Orphan Plc. Bruno's expertise spans across clinical trial submissions, regulatory strategies, and drug development consultancy, demonstrating a commitment to accelerating the availability of innovative therapies. Bruno holds a Master’s degree in Business Economics and a Bio-engineering degree from Ghent University, alongside a postgraduate certification in Health Economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices